Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Symbotic (SYM) Asset Writedowns and Impairment (2022 - 2025)

Historic Asset Writedowns and Impairment for Symbotic (SYM) over the last 4 years, with Q4 2025 value amounting to $4.8 million.

  • Symbotic's Asset Writedowns and Impairment rose 60232.56% to $4.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $11.3 million, marking a year-over-year decrease of 6673.74%. This contributed to the annual value of $7.1 million for FY2025, which is 7855.39% down from last year.
  • Latest data reveals that Symbotic reported Asset Writedowns and Impairment of $4.8 million as of Q4 2025, which was up 60232.56% from $2.2 million recorded in Q3 2025.
  • Symbotic's 5-year Asset Writedowns and Impairment high stood at $34.2 million for Q1 2024, and its period low was -$775000.0 during Q3 2024.
  • Moreover, its 4-year median value for Asset Writedowns and Impairment was $1.6 million (2022), whereas its average is $5.6 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first crashed by 10534.48% in 2024, then skyrocketed by 239298.25% in 2025.
  • Symbotic's Asset Writedowns and Impairment (Quarter) stood at $987000.0 in 2022, then crashed by 92.91% to $70000.0 in 2023, then soared by 882.86% to $688000.0 in 2024, then soared by 602.33% to $4.8 million in 2025.
  • Its last three reported values are $4.8 million in Q4 2025, $2.2 million for Q3 2025, and $3.9 million during Q2 2025.